Ryan M. Confer's most recent trade in Genprex Inc was a trade of 45,000 Common Stock done . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Genprex Inc | Ryan M. Confer | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2025 | 45,000 | 45,661 (0%) | 0% | 0 | Common Stock | |
| Genprex Inc | Ryan M. Confer | Director, President, CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 30 Jun 2025 | 5,775 | 32,968 (0%) | 0% | 0.2 | 1,316 | Common Stock |
| Genprex Inc | Ryan M. Confer | Director, President, CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 18 Feb 2025 | 395 | 38,743 (0%) | 0% | 0.4 | 162 | Common Stock |
| Genprex Inc | Ryan M. Confer | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 29,375 | 39,138 (0%) | 0% | 0 | Common Stock | |
| Genprex Inc | M. Confer Ryan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.40 per share. | 18 Feb 2024 | 1,126 | 9,763 (0%) | 0% | 4.4 | 4,954 | Common Stock |
| Genprex Inc | Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 245,000 | 435,499 (1%) | 0% | 0 | Common Stock | |
| Genprex Inc | Ryan M. Confer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2022 | 116,973 | 0 | - | - | Stock Option (right to buy) | |
| Genprex Inc | Ryan M. Confer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.02 per share. | 28 Jul 2022 | 116,973 | 190,499 (0%) | 0% | 0.0 | 1,755 | Common Stock |
| Genprex Inc | Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 341,750 | 341,750 | - | - | Stock Option (right to buy) | |
| Genprex Inc | Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 235,000 | 235,000 | - | - | Stock Option (right to buy) |